Edison Oncology Holding Corp. (EOHC)
Edison Oncology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
2,827,777
Deal Size
$25.45M
Company Description
Edison Oncology is a clinical-stage biopharmaceutical company focused on developing innovative small-molecule therapies for cancer by unlocking the potential of existing drugs and compounds.
We seek to make meaningful improvements through strategic reformulation and / or repurposing using a modernized understanding of their mechanisms of action to address significant unmet medical needs.
Our development strategy prioritizes product candidates that may qualify for accelerated marketing approval under the U.S. Food and Drug Administration’s expedited approval pathway for serious conditions.
Edison Oncology Holding Corp.
| Country | United States |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Jeffrey Bacha BSc, MBA |
Contact Details
Address: 3475 Edison Way, Suite R Menlo Park, CA 94025 United States | |
| Phone | (650) 690-1927 |
| Website | edisononcology.com |
Stock Details
| Ticker Symbol | EOHC |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1753347 |
| Employer ID | 83-1614120 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dennis M. Brown, PhD | Chairman, Chief Scientific Officer and Director |
| Jeffrey Bacha BSc, MBA | Chief Executive Officer (Principal Executive Officer) and Director |
| John Bell | Director |
| Neil Sankar, MD | Chief Medical Officer |
| Anthony Scott Praill | Chief Financial Officer (Principal Accounting Officer) |
| Richard Daniels | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 28, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Nov 14, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Oct 2, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Sep 15, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 11, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 18, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Feb 14, 2025 | DRS | [Cover] Draft Registration Statement |
| Jun 30, 2023 | DRS | [Cover] Draft Registration Statement |
| Apr 7, 2021 | D | Notice of Exempt Offering of Securities |
| Oct 12, 2018 | D | Notice of Exempt Offering of Securities |